Clinical Trial Update: Effect of Dapagliflozine on Systemic and Renal Endothelial Function [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update assesses the impact of dapagliflozin on systemic and renal endothelial function in individuals with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Endothelial Function, Type 2 Diabetes | Phase 4 | Status: UNKNOWN